XORTX Therapeutics Announces US$1.1 Million Registered Direct Offering
I'm PortAI, I can summarize articles.
XORTX Therapeutics Inc. has announced a registered direct offering of approximately US$1.1 million through a securities purchase agreement with an institutional investor. The offering includes 1,746,631 common shares priced at US$0.63 each, with proceeds intended for working capital and general corporate purposes. D. Boral Capital LLC is the sole placement agent, and the offering is subject to customary closing conditions and TSX Venture Exchange approval.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments